Although it was not supported by advanced evidence-based medical studies, it has been widely applied in the clinical field, and these studies reflected the effectiveness of RTX in patients with anti-Musk positive and some anti-AChR positive MG (59, 60). Here, MUSK is linked to myasthenia gravis.